# EDGAR Filing Document

**Accession Number:** 0000718937
**File Stem:** 0001731487-26-000002
**Filing Date:** 2026-3
**Character Count:** 7922
**Document Hash:** b38519961266d60712df336607dd3e94
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001731487-26-000002.hdr.sgml**: 20260316

**ACCESSION NUMBER**: 0001731487-26-000002

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260312

**FILED AS OF DATE**: 20260316

**DATE AS OF CHANGE**: 20260316

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Michna Magda
- **CENTRAL INDEX KEY:** 0001731487

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-11634
- **FILM NUMBER:** 26757708

**MAIL ADDRESS:**
- **STREET 1:** C/O PRESBIA
- **STREET 2:** 8845 IRVINE CENTER DRIVE, SUITE 100
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92618
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STAAR SURGICAL CO
- **CENTRAL INDEX KEY:** 0000718937
- **STANDARD INDUSTRIAL CLASSIFICATION:** OPHTHALMIC GOODS [3851]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 953797439
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0102

**BUSINESS ADDRESS:**
- **STREET 1:** 1911 WALKER AVE
- **CITY:** MONROVIA
- **STATE:** CA
- **ZIP:** 91016
- **BUSINESS PHONE:** 6263037902

**MAIL ADDRESS:**
- **STREET 1:** 1911 WALKER AVE
- **CITY:** MONROVIA
- **STATE:** CA
- **ZIP:** 91016

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** STAAR SURGICAL COMPANY
- **DATE OF NAME CHANGE:** 19920703

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Michna Magda<br><sub>(Last) (First) (Middle)</sub><br>25510 COMMERCENTRE DRIVE<br><sub>(Street)</sub><br>LAKE FOREST, CA 92630<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-03-12 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Development Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>STAAR SURGICAL CO [ STAA ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-03-12 |  | M |  | 6178<sup>(1)</sup> | A | $0 | 20622 | D |  |
| Common Stock | 2026-03-12 |  | F |  | 2216<sup>(1)</sup> | D | $18.39 | 18406 | D |  |
| Common Stock | 2026-03-14 |  | M |  | 14663<sup>(3)</sup> | A | $0 | 33069 | D |  |
| Common Stock | 2026-03-14 |  | M |  | 2932<sup>(4)</sup> | A | $0 | 36001 | D |  |
| Common Stock | 2026-03-14 |  | F |  | 6313<sup>(3)(4)</sup> | D | $18.84 | 29668<sup>(5)</sup> | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | 0<sup>(6)</sup> | 2026-03-12 |  | M |  |  | 6178 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 6178 | $0 | 6178 | D |  |
| Restricted Stock Units | 0<sup>(6)</sup> | 2026-03-13 |  | A |  | 33838 |  | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 33838 | $0 | 33838 | D |  |
| Restricted Stock Units | 0<sup>(6)</sup> | 2026-03-14 |  | M |  |  | 14663 | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 14663 | $0 | 29326 | D |  |
| Restricted Stock Units | 0<sup>(6)</sup> | 2026-03-14 |  | M |  |  | 2932 | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 2932 | $0 | 5866 | D |  |

---

### Footnotes:

(1) Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, 1/3 (6,178 shares) on March 12, 2026, and will vest as to 1/3 (6,178 shares) on March 12, 2027.  On March 12, 2026, 2,216 shares were witheld upon vesting to satisfy taxes.

(2) Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (11,279 shares) on March 13, 2027, 1/3 (11,279 shares) on March 13, 2028, and 1/3 (11,280 shares) on March 13, 2029.

(3) Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (14,663 shares) on March 14, 2026, and will vest as to 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028.  On March 14, 2026, 5,261 shares were witheld upon vesting to satisfy taxes.

(4) Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (2,932 shares) on March 14, 2026, and will vest as to 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028.  On March 14, 2026, 1,052 shares were witheld upon vesting to satisfy taxes.

(5) Includes previously granted RSUs, which are subject to future vesting.

(6) Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.

**Signature:** /s/ Magda Michna  
**Date:** 2026-03-16

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**